Angiotensin-converting enzyme inhibitors as inducers of adverse cutaneous reactions

Acta Dermato-Venereologica

Volumn 81, Issue 5, 2001, Pages 321-325

  Steckelings, U M ^a   Artuc, M ^a   Wollschlager T ^a   Wiehstutz, S ^a   Henz, B M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

ACE inhibitors; Adverse events; Angioedema; Angiotensin; Losartan

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN I; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENKEPHALIN; LOSARTAN; METALLOPROTEINASE; PEPTIDE HORMONE; SUBSTANCE P; VASOPRESSIN;

ANGIONEUROTIC EDEMA; BULLOUS SKIN DISEASE; ENZYME ACTIVE SITE; ENZYME INHIBITION; HAIR LOSS; HUMAN; HYPERKALEMIA; HYPOTENSION; INCIDENCE; KIDNEY FAILURE; PHOTOSENSITIVITY; PRIORITY JOURNAL; PRURITUS; RASH; REVIEW; SKIN ALLERGY; URTICARIA;

ACANTHOLYSIS; ANGIONEUROTIC EDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DRUG ERUPTIONS; HUMANS; LOSARTAN; RISK FACTORS; SKIN DISEASES, VESICULOBULLOUS; URTICARIA;

EID: 0035675542     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/000155501317140007     Document Type: Review

References (63)

1. ACE inhibitors in hypertension
2. ACE inhibitors in the management of cardiac failure
3. Adverse effects of enalapril in the studies of left ventricular dysfunction (SOLVD)
4. Adverse reactions to ACE inhibitors
5. Basic cardiovascular pharmacology of ACE inhibitors
6. A specific β2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril
7. Circulating versus local renin-angiotensin system in cardiovascular homeostasis
8. Angiotensin receptor stimulation of transforming growth factor-β in rat skin and wound healing
9. Normal skin as a potential source for angiotensin II
10. ACE inhibitor-induced cough and bronchospasm. Incidence, mechanisms and management
11. Female sex as an important determinant of lisinopril-induced cough
12. Airway responsiveness and cough induced by angiotensin converting enzyme inhibition
13. Sensitivity of the human cough reflex: Effect of inflammatory mediators prostaglandin E2, bradykinin and histamine
14. ACE inhibitor-induced angioedema. Incidence, prevention and management
15. Überempfindlichkeitsreaktionen auf angiotensin-converting-enzyme-hemmer
16. Visceral angioedema related to treatment with an ACE inhibitor
17. Angiotensin-converting enzyme inhibitor-induced angioedema: Late onset, irregular course, and potential role of triggers
18. Recurrent angiotensin-converting enzyme inhibitor-associated angioedema
19. Angioedema due to ACE inhibitors: Increased risk in patients of African origin
20. Effect of enalapril on the skin response to bradykinin in man
21. A comparison of captopril and enalapril on skin responses to intradermal bradykinin and skin blood flow in the human forearm
22. Absence of potentiation of the skin response to intradermal bradykinin by a long-acting angiotensin converting enzyme inhibitor, trandalopril, at conventional antihypertensive dosage in human volunteers: A double-blind, randomized, cross-over, placebo-controlled trial
23. Cutaneous blood flow changes and weal induced by intradermal bradykinin following pretreatment with indomethacin and captopril
24. Black Americans have an increased rate of angiotensin-converting enzyme inhibitor-associated angioedema
25. Increased sensitivity to bradykinin among African Americans
26. Severe angioedema related to ACE inhibitors in patients with a history of idiopathic angioedema
27. Contraindications to the use of ACE inhibitors in patients with Cl esterase-inhibitor deficiency
28. Predisposition to and late onset of upper airway obstruction following angiotensin-converting enzyme inhibitor therapy
29. Angioneurotic edema attributed to the use of losartan
30. Angioedema due to losartan
31. Clinical profile of angioedema associated with angiotensin-converting enzyme inhibition
32. Angioedema after substituting lisinopril for captopril
33. Angioneurotic oedema associated with two angiotensin-converting enzyme inhibitors
34. Angioedema and urticaria associated with angiotensin-converting enzyme inhibitors
35. Angiotensin-converting enzyme inhibitor-induced pemphigus: Three case reports and literature review
36. Captopril-induced pemphigus vegetans with Charcot-Leyden crystals
37. Bullous pemphigoid associated with captopril
38. Drug-induced linear IgA bullous dermatosis: Report of six cases and review of the literature
39. Captopril-induced lichen planus pemphigoides with pemphiguslike features. A case report
40. Antigen identification in drug-induced bullous pemphigoid
41. Induction of ancantholysis in organ explant culture by penicillamine and captopril
42. Are acantholysis and transglutaminase inhibition related phenomena?
43. Enalapril: A powerful in vitro non-thiol acanthlytic agent
44. Pityriasis rosea-like skin eruptions caused by captopril (Eruzione cutanea da captopril "pitiriasi rosea-like")
45. Psoriasis related to angiotensin-converting enzyme inhibitors
46. Enalapril-associated erythema and vasculitis
47. Captopril-induced lichenoid eruption
48. Nebenwirkungen von ACE-Hemmern
49. Captopril and onycholysis
50. Cutaneous reactions to captopril
51. Captopril and alopecia: A case report and review of known cutaneous reactions in captopril use
52. Adverse reactions in the skin from antihypertensive drugs
53. Comparison of type I angiotensin II receptor blockers and angiotensin converting enzyme inhibitors in the treatment of hypertension
54. The ELITE study. What are its implications for the drug treatment of heart failure? Evaluation of losartan in the elderly study
55. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomised trial - The Losartan Heart Failure Survival Study ELITE II
56. Discovery of losartan, the first angiotensin II receptor antagonist
57. Angioedema associated with angiotensin II receptor antagonist losartan
58. Angiotensin receptor antagonists and ACE inhibitors
59. Use of losartan in the treatment of hypertensive patients with a history of cough induced by angiotensin-converting enzyme inhibitors
60. Double-blind comparison of losartan, lisinopril, and metolazone in elderly hypertensive patients with previous angiotensin-converting enzyme inhibitor-induced cough
61. 2-receptors in human skin
62. Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo
63. Angiotensin II enhances integrin and alpha-actinin expression in adult rat cardiac fibroblasts